9 results on '"Martinez, R"'
Search Results
2. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study.
- Author
-
Nieto-Martinez R, Barengo NC, Restrepo M, Grinspan A, Assefi A, and Mechanick JI
- Subjects
- Male, Female, Humans, Adolescent, Adult, Cross-Sectional Studies, Finland, Latin America, Caribbean Region epidemiology, Risk Factors, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 epidemiology
- Abstract
Background: The prevalence of type 2 diabetes (T2D) continues to increase in the Americas. Identifying people at risk for T2D is critical to the prevention of T2D complications, especially cardiovascular disease. This study gauges the ability to implement large population-based organized screening campaigns in 19 Latin American and Caribbean countries to detect people at risk for T2D using the Finnish Diabetes Risk Score (FINDRISC)., Methods: This cross-sectional descriptive analysis uses data collected in a sample of men and women 18 years of age or older who completed FINDRISC via eHealth during a Guinness World Record attempt campaign between October 25 and November 1, 2021. FINDRISC is a non-invasive screening tool based on age, body mass index, waist circumference, physical activity, daily intake of fruits and vegetables, history of hyperglycemia, history of antihypertensive drug treatment, and family history of T2D, assigning a score ranging from 0 to 26 points. A cut-off point of ≥ 12 points was considered as high risk for T2D., Results: The final sample size consisted of 29,662 women (63%) and 17,605 men (27%). In total, 35% of subjects were at risk of T2D. The highest frequency rates (FINDRISC ≥ 12) were observed in Chile (39%), Central America (36.4%), and Peru (36.1%). Chile also had the highest proportion of people having a FINDRISC ≥15 points (25%), whereas the lowest was observed in Colombia (11.3%)., Conclusions: FINDRISC can be easily implemented via eHealth technology over social networks in Latin American and Caribbean populations to detect people with high risk for T2D. Primary healthcare strategies are needed to perform T2D organized screening to deliver early, accessible, culturally sensitive, and sustainable interventions to prevent sequelae of T2D, and reduce the clinical and economic burden of cardiometabolic-based chronic disease., Competing Interests: RN-M, NB, and JM received honoraria from Merck for working on this manuscript and have received honoraria for lectures in the past. The authors declare that this study received funding from Merck. Merck funded and designed the study, assisted in collecting the results and paid for the article processing charge. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Nieto-Martinez, Barengo, Restrepo, Grinspan, Assefi and Mechanick.)
- Published
- 2023
- Full Text
- View/download PDF
3. Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.
- Author
-
Ayala N, Barchuk S, Inurrigarro G, Celano C, Soriano-García JL, Bolaños P, Mohs-Alfaro M, Tapia-González H, Perez-Martinez R, Samtani S, Alvarado-Cabrero I, Villarreal-Garza C, Tamez-Salazar J, Magallanes-Garza GI, Vazquez D, Castro J, Gómez-Macías GS, Ferrigno A, Morante Z, Vilchez S, Cotrina JM, Doimi F, Santander G, Acevedo C, Ortega V, Lavista F, Richter L, Gianella M, Paredes M, Flores-Balcázar CH, Pinto JA, and Gomez HL
- Subjects
- Humans, Female, Latin America epidemiology, Quality of Life, Delivery of Health Care, Early Detection of Cancer, Breast Neoplasms diagnosis, Breast Neoplasms epidemiology, Breast Neoplasms therapy
- Abstract
The Breast Cancer Revealed initiative was designed and conducted to know the status of breast cancer at each point of breast cancer care, through i) prevention, ii) detection, iii) diagnosis, iv) treatment, and iv) the capacity of our health systems. The expert panel from 11 Latin American countries identified several strategies and proposed high impact priorities, including implementation of prevention policies, improve primary healthcare capacity for breast cancer screening, have adequate infrastructure to make effective and timely diagnoses, have a multidisciplinary team in the treatment process, access to a variety of treatments for all types of patients, have a coordinated and articulated system from primary care to specialized hospital. In a region with limited resources, prioritization in high-impact strategies for breast cancer control could lead to improved clinical outcomes and quality of life for our patients., Competing Interests: Conflict of Interest Statement JMC received grants from Roche and Genomic Health and payment for lectures from BRP Oncology Updates and Roche Bolivia. The other authors declare they have not potential conflict of interests with this research., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Open intrauterine repair of spina bifida aperta: Historical aspects, current availability, and clinical outcomes from the Latin American Spina Bifida Consortium.
- Author
-
Sepulveda W, Cruz-Martinez R, Etchegaray A, Sanin-Blair J, Ventura W, Corral E, and Marquez R
- Subjects
- Adult, Female, Gestational Age, Health Services Accessibility statistics & numerical data, Humans, Latin America epidemiology, Outcome Assessment, Health Care methods, Pregnancy, Spina Bifida Cystica complications, Spina Bifida Cystica epidemiology, Fetus surgery, Health Services Accessibility standards, Outcome Assessment, Health Care statistics & numerical data, Spina Bifida Cystica surgery
- Abstract
Objective: To determine the historical aspects, current availability, and clinical outcomes of open intrauterine repair of spina bifida aperta (IRSBA) in Spanish-speaking Latin American countries., Methods: Cases were collected from centers with at least 2 years of experience and a minimum of 10 open IRSBA interventions by December 2020. Clinical variables were compared to the results of the Management of Myelomeningocele Study (MOMS) trial., Results: Clinical experience with 314 cases from seven centers was reviewed. Most cases (n = 189, 60.2%) were performed between 24 and 25.9 weeks' gestation. Delivery at less than 30 weeks' gestation occurred in 36 cases (11.5%) and the overall perinatal mortality rate was 5.4% (17 of 314). The rate of maternal complications was low, including the need for blood transfusion (n = 3, 0.9%) and dehiscence or a thin uterine scar (n = 4, 1.3%). No cases of maternal death were recorded. Fifteen neonates required additional surgical repair of the spinal defect (4.8%) and 63 of 167 infants (37.7%) required a cerebrospinal fluid diversion procedure. Only two of the seven centers reported preliminary experience with fetoscopic IRSBA., Conclusions: Clinical experience and outcomes were within the expected results reported by the MOMS trial. There is still very limited experience with fetoscopic IRSBA in this part of the world., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
5. Cohort Profile: The Cohorts Consortium of Latin America and the Caribbean (CC-LAC).
- Author
-
Carrillo-Larco RM, Di Cesare M, Hambleton IR, Hennis A, Irazola V, Stern D, Ferreccio C, Lotufo P, Perel P, Gregg EW, Ezzati M, Danaei G, Miranda JJ, Aguilar-Salinas CA, Alvarez-Váz R, Amadio MB, Baccino C, Bambs C, Bastos JL, Beckles G, Bernabe-Ortiz A, Bernardo CDO, Bloch KV, Blümel JE, Boggia JG, Borges PK, Bravo M, Brenes-Camacho G, Carbajal HA, Castillo Rascon MS, Ceballos BH, Colpani V, Confortin SC, Cooper JA, Cortés-Valencia A, Cortes S, Cunha RS, d'Orsi E, Dow WH, Espeche WG, Fuchs FD, Fuchs SC, Gimeno SGA, Gomez-Velasco D, Gonzalez-Villalpando C, Gonzalez-Villalpando ME, Gonzalez-Chica DA, Grazioli G, Guerra RO, Gutierrez L, Herkenhoff FL, Horimoto ARVR, Huidobro A, Koch E, Lajous M, Lima-Costa MF, Lopez-Ridaura R, Maciel ACC, Manrique-Espinoza BS, Marques LP, Mill JG, Moreira LB, Ono LM, Muñoz OM, Oppermann K, Peixoto SV, Pereira AC, Peres KG, Peres MA, Rodriguez NI, Rojas-Martinez R, Rosero-Bixby L, Rubinstein A, Ruiz-Morales A, Salazar MR, Salinas-Rodriguez A, Sanchez RA, Schneider IJC, Silva TLN, Silva NAS, Smeeth L, Spritzer PM, Tartaglione F, and Tartaglione J
- Subjects
- Caribbean Region, Cohort Studies, Humans, Latin America epidemiology, Ethnicity
- Published
- 2020
- Full Text
- View/download PDF
6. Brazilian guidelines for the clinical management of paracoccidioidomycosis.
- Author
-
Shikanai-Yasuda MA, Mendes RP, Colombo AL, Queiroz-Telles F, Kono ASG, Paniago AMM, Nathan A, Valle ACFD, Bagagli E, Benard G, Ferreira MS, Teixeira MM, Silva-Vergara ML, Pereira RM, Cavalcante RS, Hahn R, Durlacher RR, Khoury Z, Camargo ZP, Moretti ML, and Martinez R
- Subjects
- Brazil, Consensus, Diagnosis, Differential, Humans, Itraconazole therapeutic use, Latin America, Paracoccidioides, Antifungal Agents therapeutic use, Disease Management, Paracoccidioidomycosis drug therapy, Paracoccidioidomycosis pathology
- Abstract
Paracoccidioidomycosis is a systemic fungal disease occurring in Latin America that is associated with rural environments and agricultural activities. However, the incidence and prevalence of paracoccidiodomycosis is underestimated because of the lack of compulsory notification. If paracoccidiodomycosis is not diagnosed and treated early and adequately, the endemic fungal infection could result in serious sequelae. While the Paracoccidioides brasiliensis ( P. brasiliensis ) complex has been known to be the causal agent of paracoccidiodomycosis, a new species, Paracoccidioides lutzii ( P. lutzii ), has been reported in Rondônia, where the disease has reached epidemic levels, and in the Central West and Pará. Accurate diagnoses and availability of antigens that are reactive with the patients' sera remain significant challenges. Therefore, the present guidelines aims to update the first Brazilian consensus on paracoccidioidomycosis by providing evidence-based recommendations for bedside patient management. This consensus summarizes etiological, ecoepidemiological, molecular epidemiological, and immunopathological data, with emphasis on clinical, microbiological, and serological diagnosis and management of clinical forms and sequelae, as well as in patients with comorbidities and immunosuppression. The consensus also includes discussion of outpatient treatments, severe disease forms, disease prevalence among special populations and resource-poor settings, a brief review of prevention and control measures, current challenges and recommendations.
- Published
- 2017
- Full Text
- View/download PDF
7. EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS.
- Author
-
Martinez R
- Subjects
- Animals, Humans, Incidence, Latin America epidemiology, Paracoccidioidomycosis veterinary, Prevalence, Risk Factors, Paracoccidioidomycosis epidemiology
- Abstract
The epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were discussed in the section regarding the geographic distribution of the mycosis. Subclinical infection with Paracoccidioides brasiliensis was discussed on the basis of skin test surveys with antigens of the fungus, seroepidemiological studies, and disease cases outside Latin America. Large case series permitted a comparison of the prevalence of the mycosis in different regions, its estimated incidence and risk factors for the development of the disease. Aspects modulating the expression of the clinical forms of paracoccidioidomycosis are also presented. This review also deals with diseases associated with the mycosis, opportunistic paracoccidioidomycosis, lethality, mortality and infection and disease in animals.
- Published
- 2015
- Full Text
- View/download PDF
8. Hypertension Prevention and Control in Latin America and the Caribbean.
- Author
-
Ordunez P, Martinez R, Niebylski ML, and Campbell NR
- Subjects
- Antihypertensive Agents therapeutic use, Caribbean Region epidemiology, Health Planning, Humans, Hypertension drug therapy, Hypertension epidemiology, Latin America epidemiology, Hypertension prevention & control
- Published
- 2015
- Full Text
- View/download PDF
9. Paracoccidioidomycosis and AIDS.
- Author
-
Goldani LZ, Coelho IC, Machado AA, and Martinez R
- Subjects
- Adult, Amphotericin B therapeutic use, Female, Humans, Latin America, Acquired Immunodeficiency Syndrome complications, Opportunistic Infections complications, Paracoccidioidomycosis complications
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.